These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2248845)

  • 1. Pharmacokinetics of atracurium during continuous infusion.
    Beemer GH; Bjorksten AR; Crankshaw DP
    Br J Anaesth; 1990 Nov; 65(5):668-74. PubMed ID: 2248845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of atracurium during propofol, thiopentone and opioid anaesthesia.
    Beemer GH; Bjorksten AR; Crankshaw DP
    Br J Anaesth; 1990 Nov; 65(5):675-83. PubMed ID: 2248846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anesthesia.
    Tran TV; Fiset P; Varin F
    Anesth Analg; 1998 Nov; 87(5):1158-63. PubMed ID: 9806701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of a 0.1 mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia.
    Imbeault K; Withington DE; Varin F
    Anesth Analg; 2006 Mar; 102(3):738-43. PubMed ID: 16492821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of body build on the clearance of atracurium: implication for drug dosing.
    Beemer GH; Bjorksten AR; Crankshaw DP
    Anesth Analg; 1993 Jun; 76(6):1296-303. PubMed ID: 8498668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of atracurium in neonates, infants and children. A study of dose requirements.
    Kalli I; Meretoja OA
    Br J Anaesth; 1988 May; 60(6):651-4. PubMed ID: 3377949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the interaction between atracurium and suxamethonium at 50% neuromuscular block using closed-loop feedback control of infusion of atracurium.
    Olkkola KT; Tammisto T
    Br J Anaesth; 1994 Aug; 73(2):199-203. PubMed ID: 7917736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of the interaction between atracurium and succinylcholine using closed-loop feedback control of infusion of atracurium.
    Olkkola KT; Schwilden H
    Anesthesiology; 1990 Oct; 73(4):614-8. PubMed ID: 2221429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of atracurium in infants and children.
    Fisher DM; Canfell PC; Spellman MJ; Miller RD
    Anesthesiology; 1990 Jul; 73(1):33-7. PubMed ID: 2360737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
    Beattie WS; Buckley DN; Forrest JB
    Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration.
    Shearer ES; O'Sullivan EP; Hunter JM
    Br J Anaesth; 1991 Nov; 67(5):569-73. PubMed ID: 1751271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
    Farenc C; Lefrant JY; Audran M; Bressolle F
    J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of atracurium with and without previous suxamethonium administration.
    Donati F; Gill SS; Bevan DR; Ducharme J; Theoret Y; Varin F
    Br J Anaesth; 1991 May; 66(5):557-61. PubMed ID: 2031815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of atracurium in clinical practice: effect of plasma potassium, patient demographics, and concurrent medication.
    Beemer GH; Bjorksten AR
    Anesth Analg; 1993 Jun; 76(6):1288-95. PubMed ID: 8498667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of propofol infusions in paediatric anaesthesia: a practical guide.
    McFarlan CS; Anderson BJ; Short TG
    Paediatr Anaesth; 1999; 9(3):209-16. PubMed ID: 10320599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg
    Aguilar A; Andaluz A; Moll X; Cristòfol C; García F
    Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation.
    Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF
    Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients.
    Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ
    Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile in relation to anaesthesia characteristics after a 5% micellar microemulsion of propofol in the horse.
    Boscan P; Rezende ML; Grimsrud K; Stanley SD; Mama KR; Steffey EP
    Br J Anaesth; 2010 Mar; 104(3):330-7. PubMed ID: 20053624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.